Selbyville, Delaware, Dec. 10, 2024 (GLOBE NEWSWIRE) --
Veterinary anti-infectives market size was valued at USD 5.4 billion in 2023, is expected to expand at a CAGR of 3.5% from 2024 to 2032. This growth is driven by the rising prevalence of infectious diseases in livestock and companion animals.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/12126
Anti-infective treatments are essential for managing bacterial, viral, and fungal infections, preventing potential disease outbreaks that can result in significant economic losses in agriculture. Additionally, they help improve the overall well-being of companion animals, contributing to the growing demand for effective treatments in the sector.
The veterinary anti-infectives market is divided into two segments based on animal type: livestock and companion animals. The livestock segment is anticipated to remain dominant, holding the largest revenue share in 2023, and is projected to maintain its leadership throughout the forecast period with a growth rate of 3.4%. This dominance is driven by the need for disease management and prevention in large-scale farming operations. Rising global demand for meat, along with increased awareness of animal health, further propels the adoption of anti-infective solutions in livestock management.
The veterinary anti-infectives market is further categorized by product type, including antibacterial, antifungal, antivirals, and antiparasitics. Among these, the antibacterial segment holds the largest market share, accounting for 44.3% in 2023, and is expected to remain the leading category. This is due to the critical role antibiotics play in addressing bacterial infections in both livestock and companion animals. The growing prevalence of bacterial diseases and the ongoing challenges posed by antibiotic resistance highlight the importance of continuous innovation and research in developing antibacterial treatments.
Request for Report Customization @ https://www.gminsights.com/roc/12126
In North America, the veterinary anti-infectives market is poised for significant expansion, with the U.S. contributing USD 2 billion in 2023. Factors such as a well-established healthcare infrastructure, heavy investment in research and development, and a high incidence of infectious diseases in humans and animals support the market's expansion. The U.S. also benefits from a strict regulatory framework that ensures the safety and efficacy of anti-infective products. Increasing pet ownership and rising demand for livestock products continue to drive the need for veterinary anti-infectives, making the U.S. a key player in the global market.
Partial Table of Contents (ToC) of the report:
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of zoonotic diseases among animals
3.2.1.2 Growing advancements in veterinary medicines
3.2.1.3 Increasing demand for meat and animal products
3.2.1.4 Growing government initiatives to control animal diseases
3.2.2 Industry pitfalls & challenges
3.2.2.1 Rising concerns over antibiotic resistance
3.2.2.2 Stringent regulatory challenges
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter's analysis
3.7 PESTEL analysis
Browse more veterinary pharmaceuticals industry reports @ https://www.gminsights.com/industry-reports/veterinary-pharmaceuticals/94
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
